Literature DB >> 17563132

Measurement of the effects of abstinence from tobacco: a qualitative review.

John R Hughes1.   

Abstract

This article reviews terms, methodologies, and scales used to describe the effects of abstinence from tobacco in humans. The review suggests operational definitions for withdrawal, offset, novel, and indefinite abstinence effects. The review recommends the use of prospective studies that use smokers trying to quit, multiple data points pre-abstinence and very soon after abstinence, comparison groups, at least 16 hrs of abstinence, objective measures, measures of clinical significance, and data analytic techniques that allow use of all participants' data. The 8 most commonly used tobacco withdrawal measures differ in coverage, brevity, and use of single vs. multiple items to describe each symptom. Of the measures, 6 consistently increase with abstinence, but no single measure appears superior.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563132     DOI: 10.1037/0893-164X.21.2.127

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  39 in total

1.  Validation of the Avoidance and Inflexibility Scale (AIS) among treatment-seeking smokers.

Authors:  Samantha G Farris; Michael J Zvolensky; Angelo M DiBello; Norman B Schmidt
Journal:  Psychol Assess       Date:  2015-02-02

2.  Advancing the understanding of craving during smoking cessation attempts: a demonstration of the time-varying effect model.

Authors:  Stephanie T Lanza; Sara A Vasilenko; Xiaoyu Liu; Runze Li; Megan E Piper
Journal:  Nicotine Tob Res       Date:  2013-08-24       Impact factor: 4.244

3.  Gender differences in self-reported withdrawal symptoms and reducing or quitting smoking three years later: A prospective, longitudinal examination of U.S. adults.

Authors:  Andrea H Weinberger; Jonathan M Platt; Jonathan Shuter; Renee D Goodwin
Journal:  Drug Alcohol Depend       Date:  2016-06-20       Impact factor: 4.492

4.  Smoking abstinence and reinstatement effects in adolescent cigarette smokers.

Authors:  Suzanne M Colby; Adam M Leventhal; Linda Brazil; Johanna Lewis-Esquerre; L A R Stein; Damaris J Rohsenow; Peter M Monti; Raymond S Niaura
Journal:  Nicotine Tob Res       Date:  2009-11-23       Impact factor: 4.244

Review 5.  Withdrawal: Expanding a Key Addiction Construct.

Authors:  Megan E Piper
Journal:  Nicotine Tob Res       Date:  2015-03-05       Impact factor: 4.244

Review 6.  Toward empirical identification of a clinically meaningful indicator of treatment outcome: features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes.

Authors:  Kathleen M Carroll; Brian D Kiluk; Charla Nich; Elise E DeVito; Suzanne Decker; Donna LaPaglia; Dianne Duffey; Theresa A Babuscio; Samuel A Ball
Journal:  Drug Alcohol Depend       Date:  2014-01-31       Impact factor: 4.492

7.  Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disorders.

Authors:  Andrea H Weinberger; Rani A Desai; Sherry A McKee
Journal:  Drug Alcohol Depend       Date:  2009-12-16       Impact factor: 4.492

8.  Pain as a predictor and consequence of tobacco abstinence effects amongst African American smokers.

Authors:  Mariel S Bello; Julia F McBeth; Joseph W Ditre; Matthew G Kirkpatrick; Lara A Ray; Kelly E Dunn; Adam M Leventhal
Journal:  J Abnorm Psychol       Date:  2018-08-02

9.  Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample.

Authors:  Jill Hardin; Yungang He; Harold S Javitz; Jennifer Wessel; Ruth E Krasnow; Elizabeth Tildesley; Hyman Hops; Gary E Swan; Andrew W Bergen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 10.  A review of epidemiologic research on smoking behavior among persons with alcohol and illicit substance use disorders.

Authors:  Andrea H Weinberger; Allison P Funk; Renee D Goodwin
Journal:  Prev Med       Date:  2016-05-16       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.